2012 Dinner Symposium

The New Microbiota & Probiotics Paradigm: from Mechanisms to Clinical Applications

May 21, 2012
San Diego, California

Challenges in gastrointestinal disorders prevention and health promotion underscore the importance of the genetic makeup mapping of gut microbiota. This new area of research will put into context how the use of probiotics can be optimized to maintain the stability of beneficial microbiota and disrupt the colonization of gut by harmful organisms. Linking this understanding to probiotic research and application in areas such as IBS represents a new frontier for promoting health and preventing and managing certain disorders.

In May 2012, a world-class panel of experts shared insights about the latest research and clinical applications on how probiotics may be used effectively in clinical practice to promote a stable, healthy balance of gut microbiota.

No webcast recordings of this event are available.

Welcome and Introductory Comments

W. Allan Walker, M.D.
Conrad Taff Professor of Nutrition and Pediatrics, Harvard Medical School
Director, Mucosal Immunology Laboratory; Massachusetts General Hospital

Stability and Disrupting the Microbiota

Patrick Schloss, PhD
Assistant Professor,
Department of Microbiology & Immunology,
University of Michigan

Intestinal Dysbiosis as a Basis for Functional Gastrointestinal Disorders

Stephen M. Collins, MBBS, FRCP(UK), FRCPC
Associate Dean, Research, Faculty of Health Sciences Professor, Department of Medicine;
Assistant Clinical Professor, Michael G. Degroote School of Medicine,
McMaster University

Restoring a Healthy Microbiota: What Tools Do We Have?

R. Balfour Sartor, MD
Midgett Distinguished Professor of Medicine, Microbiology & Immunology;
Director, UNC Multidisciplinary Center for IBD Research and Treatment;
Co-Director, Center for Gastrointestinal Biology and Disease,
UNC Department of Medicine/Division of Gastroenterology and Hepatology

Q&A Discussion

Full Panel